6.38
5.45%
0.33
시간 외 거래:
6.40
0.02
+0.31%
Verve Therapeutics Inc (VERV) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
10.71%
5.695
|
5.144 | 3.117 | 2.093 | 1.404 |
Operating Expenses
|
5.83%
62.54
|
59.09 | 55.45 | 60.68 | 59.66 |
Benefits Costs and Expenses |
1.61%
54.33
|
53.46 | 48.81 | 55.90 | 53.38 |
Costs And Expenses |
5.83%
62.54
|
59.09 | 55.45 | 60.68 | 59.66 |
Depreciation and Amortization |
7.58%
1.632
|
1.517 | 1.474 | 1.337 | 1.127 |
Operating Income/Loss |
5.37%
-56.84
|
-53.95 | -52.33 | -58.58 | -58.26 |
Nonoperating Income/Loss |
45.95%
8.214
|
5.628 | 6.643 | 4.776 | 6.284 |
Income/Loss From Continuing Operations Before Tax |
0.64%
-48.63
|
-48.32 | -45.69 | -53.81 | -51.98 |
Income Tax Expense/Benefit |
231.25%
0.106
|
0.032 | 0.067 | 0.176 | - |
Income/Loss From Continuing Operations After Tax |
0.79%
-48.74
|
-48.35 | -45.76 | -53.98 | -51.98 |
Net Income/Loss
|
0.79%
-48.74
|
-48.35 | -45.76 | -53.98 | -51.98 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,388%
83.13
|
1.8522 | 63.21 | 61.95 | 61.79 |
Diluted Average Shares |
4,388%
83.13
|
1.8522 | 63.21 | 61.95 | 61.79 |
Basic Earnings Per Share |
14.49%
-0.59
|
-0.69 | -0.72 | -0.87 | -0.84 |
Diluted Earnings Per Share |
14.49%
-0.59
|
-0.69 | -0.72 | -0.87 | -0.84 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):